Your browser doesn't support javascript.
loading
The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer.
Beyer, Katharina; MacLennan, Sara J; Moris, Lisa; Lardas, Michael; Mastris, Ken; Hooker, Gary; Greene, Robert; Briers, Erik; Omar, Muhammad Imran; Healey, Jemma; Tripathee, Sheela; Gandaglia, Giorgio; Venderbos, Lionne D F; Smith, Emma J; Bjorkqvist, Josefine; Asiimwe, Alex; Huber, Johannes; Roobol, Monique J; Zong, Jihong; Bjartell, Anders; N'Dow, James; Briganti, Alberto; MacLennan, Steven; Van Hemelrijck, Mieke.
Afiliação
  • Beyer K; Translational and Oncology Research, Faculty of Life Sciences and Medicine, King's College London, London, UK. Electronic address: katharina.beyer@kcl.ac.uk.
  • MacLennan SJ; Academic Urology Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
  • Moris L; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Lardas M; Department of Urology, Metropolitan general, Athens, Greece.
  • Mastris K; European Cancer Patient Coalition, Brussels, Belgium.
  • Hooker G; Patient representative, London, UK.
  • Greene R; HungerNdThirst, Amsterdam, The Netherlands.
  • Briers E; EAU Guidelines Office Prostate Cancer Panel, Hasselt, Belgium.
  • Omar MI; Academic Urology Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
  • Healey J; Academic Urology Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
  • Tripathee S; Academic Urology Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
  • Gandaglia G; Department of Urology, University Vita e Salute-San Raffaele, Milan, Italy.
  • Venderbos LDF; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Smith EJ; European Association of Urology Guidelines Office, Arnhem, The Netherlands.
  • Bjorkqvist J; Department of Urology, Metropolitan general, Athens, Greece.
  • Asiimwe A; Department of Epidemiology, Bayer AG, Berlin, Germany.
  • Huber J; Department of Urology, University Dresden, Dresden, Germany.
  • Roobol MJ; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Zong J; Global Medical Affairs Oncology, Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA.
  • Bjartell A; Department of Translational Medicine, Lund University, Malmö, Sweden.
  • N'Dow J; Academic Urology Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK; European Association of Urology Guidelines Office, Arnhem, The Netherlands.
  • Briganti A; Department of Urology, University Vita e Salute-San Raffaele, Milan, Italy.
  • MacLennan S; Academic Urology Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
  • Van Hemelrijck M; Translational and Oncology Research, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Eur Urol Focus ; 7(5): 943-946, 2021 09.
Article em En | MEDLINE | ID: mdl-34602368
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Participação do Paciente / Neoplasias da Próstata Tipo de estudo: Guideline Aspecto: Patient_preference Limite: Humans / Male Idioma: En Revista: Eur Urol Focus Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Participação do Paciente / Neoplasias da Próstata Tipo de estudo: Guideline Aspecto: Patient_preference Limite: Humans / Male Idioma: En Revista: Eur Urol Focus Ano de publicação: 2021 Tipo de documento: Article